pcDNA Plasmids
pcDNA plasmids are a family of eukaryotic expression vectors designed for high-level transient or stable expression of recombinant genes in mammalian cells. These plasmids are widely used in molecular biology and biomedical research for gene function studies, protein production, and therapeutic applications. The pcDNA name reflects their utility in plasmid-based DNA expression systems.
Key Features of pcDNA Plasmids
- CMV Promoter:
- A strong, constitutive promoter derived from the cytomegalovirus (CMV) immediate-early gene for high-level expression in a wide range of mammalian cells.
- Multiple Cloning Site (MCS):
- Contains multiple unique restriction sites for easy insertion of the gene of interest.
- Polyadenylation Signal (Poly-A):
- A bovine growth hormone (BGH) polyadenylation signal ensures proper termination and polyadenylation of mRNA transcripts.
- Selectable Markers:
- Neomycin Resistance (neo): Provides resistance to G418 in mammalian cells for stable transfection.
- Ampicillin Resistance (ampR): Confers antibiotic resistance for selection in E. coli.
Applications of pcDNA Plasmids
- RNA Interference (RNAi):
- Some pcDNA plasmids are adapted for expressing short hairpin RNA (shRNA) for gene silencing.
- Gene Therapy Research:
- Used as a platform for testing DNA-based therapeutic strategies in preclinical models.
- Reporter Assays:
- Reporter gene constructs (e.g., luciferase, GFP) in pcDNA vectors are used to study promoter activity or protein localization.
- Vaccine Development:
- Supports DNA vaccine research by expressing antigens in mammalian cells.
- Crispr/Cas Systems:
- Adapted versions of pcDNA plasmids can be used for expressing Cas9 or gRNAs in genome editing applications.
pcDNA plasmids are powerful tools for high-level gene expression in mammalian cells. Their strong CMV promoter, versatility, and compatibility with various applications make them a go-to choice for protein production, functional genomics, and therapeutic research. These plasmids provide a reliable platform for advancing molecular and biomedical studies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|